date,title,source
Oct-30-18,Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope,GlobeNewswire
Nov-01-18,Will Fortress Biotech (FBIO) Report Negative Earnings Next Week? What You Should Know,Zacks
Nov-09-18,"Fortress Biotech (FBIO) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-09-18,Fortress Biotech: 3Q Earnings Snapshot,Associated Press
Nov-09-18,Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Nov-13-18,InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.,GlobeNewswire
Nov-14-18,"Consolidated Research: 2018 Summary Expectations for Franco-Nevada, CPS Technologies, I.D., Fortress Biotech, Avalon, and Key Tronic  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Nov-19-18,"Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial",GlobeNewswire
Nov-19-18,B. Riley Financial Enters Agreement to Purchase Fortress Biotechs Stake in National Holdings,GlobeNewswire
Nov-19-18,B. Riley Financial Enters a Definitive Agreement to Purchase Fortress Biotechs Stake in National Holdings Corporation,GlobeNewswire
Nov-20-18,Fortress Biotech (FBIO) in Focus: Stock Moves 6.5% Higher,Zacks
Dec-12-18,"Should You Worry About Fortress Biotech, Inc.s (NASDAQ:FBIO) CEO Pay?",Simply Wall St.
Dec-19-18,Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain,GlobeNewswire
Dec-20-18,Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm,GlobeNewswire
Dec-21-18,Fortress Biotech Recaps Corporate Highlights and Achievements in 2018,GlobeNewswire
Jan-02-19,"Report: Exploring Fundamental Drivers Behind Energy Transfer LP, Cable One, DTE Energy, Civitas Solutions, Owens Realty Mortgage, and Fortress Biotech  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Jan-28-19,ATXI: How Much Are CVRs Worth?,Zacks Small Cap Research
Jan-31-19,4 Biotech Stocks Making Moves On Thursday (1/31/19),ACCESSWIRE
Jan-31-19,Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals,GlobeNewswire
Feb-01-19,"Fortress BioTech, Late Stage Development Progress and Caelum Partnership with Alexion",ACCESSWIRE
Feb-01-19,Biotechs to Put on Your Watchlist,ACCESSWIRE
Feb-05-19,Biotech on the Brink of Breaking Out,ACCESSWIRE
Feb-11-19,Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary),GlobeNewswire
Feb-12-19,Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation,GlobeNewswire
